Eosinophilic Pleural Effusion Induced by Paliperidone Palmitate: Case Report and  Literature Review.

R8P8USM8FR (Paliperidone Palmitate); Eosinophilia/chemically induced/complications; Exudates and Transudates; Humans; Leukocyte Count; Paliperidone Palmitate/adverse effects; Pleural Effusion/chemically induced/complications/diagnosis; case report; drug-induced eosinophilic pleural effusion; eosinophilic pleural effusion; iatrogenic pleural effusion; paliperidone palmitate

Abstract :

[en] BACKGROUND: Eosinophilic pleural effusions are defined by an eosinophil count ≥ 10% in pleural fluid and represent approximately 10% of exudative pleural effusions. They are associated with a large spectrum of etiologies, both benign and malignant. Drug-induced eosinophilic pleural effusions remain rarely described. OBJECTIVE AND METHODS: After ruling out other causes with a careful diagnostic assessment, we retain paliperidone as the etiology, given the disappearance of the pleural effusion after drug discontinuation. RESULTS: We report the first case of eosinophilic pleural effusion induced by paliperidone palmitate treatment. CONCLUSION: After considering other etiologies, drug-induced eosinophilic pleural effusion should be sought.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

de Ghellinck, Léopold; Pneumology Department, Centre Hospitalier de l'Ardenne, Libramont-Chevigny,

FRUSCH, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie ; Pneumology Department, Centre Hospitalier de l'Ardenne, Libramont-Chevigny,

Duysinx, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie

Language :

English

Title :

Eosinophilic Pleural Effusion Induced by Paliperidone Palmitate: Case Report and Literature Review.

Publication date :

2022

Journal title :

Journal of the Academy of Consultation-Liaison Psychiatry

ISSN :

2667-2979

eISSN :

2667-2960

Volume :

Issue :

Pages :

394-399

Peer reviewed :

Peer reviewed

Commentary :

Available on ORBi :

since 12 January 2023

Statistics

Number of views

79 (0 by ULiège)

Number of downloads

41 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Hirsch, A., Ruffie, P., Nebut, M., Bignon, J., Chretien, J., Pleural effusion: laboratory tests in 300 cases. Thorax 34 (1979), 106–112.
Rubins, J.B., Rubins, H.B., Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study selection of cases. Chest 110 (1996), 1271–1274.
Martínez-Garcìa, M.A., Cases-Viedma, E., Cordero-Rodrìguez, P.J., et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 15 (2000), 166–169.
Oba, Y., Abu-Salah, T., The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration 83 (2012), 198–208.
Zouak, A., Bongrain, E., Launois, C., et al. Pleurésie à éosinophiles: une complication rare d'un traitement par inhibiteur de l'enzyme de conversion de l'angiotensine. Rev Mal Respir 32 (2015), 737–741.
Adelman, M., Albelda, S.M., Gottlieb, J., Haponik, E.F., Diagnostic utility of pleural fluid eosinophilia. Am J Med 77 (1984), 915–920.
Alphs, L., Benson, C., Cheshire-Kinney, K., et al. Real-world outcomes of paliperidone palmitate compared to daily oral antipsychotic therapy in schizophrenia: a randomized, open-label, review board-blinded 15-month study. J Clin Psychiatry 76 (2015), 554–561.
Huggins, J.T., Chopra, A., Pleural Fluid Eosinophilia. Available from: https://www.uptodate.com/contents/pleural-fluid-eosinophilia?search=pleural fluideosinophilia&source=search_result&selectedTitle=1∼20&usage_type=default&display_rank=1.
Huggins, J.T., Sahn, S.A., Drug-induced pleural disease. Clin Chest Med 25 (2004), 141–153.
Camus, P., Eosinophilic Pleural Effusion. Available from: https://www.pneumotox.com/pattern/view/32/V.b/eosinophilic-pleural-effusion.
Rothenberg, M.E., Eosinophilia. N Engl J Med 338 (1998), 1592–1600.
Heidecker, J., Kaplan, A., Sahn, S.A., Pleural fluid and peripheral eosinophilia from hemothorax: hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. Am J Med Sci 332 (2006), 148–152.
Katayama, H., Yokoyama, A., Kohno, N., et al. Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol 26 (2002), 398–403.
Kalomenidis, I., Light, R.W., Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med 10 (2004), 289–293.
Kalomenidis, I., Light, R.W., Eosinophilic pleural effusions. Curr Opin Pulm Med 9 (2003), 254–260.
Georas, S.N., Beck, L.A., Stellato, C., What is eotaxin doing in the pleura? Insights into innate immunity from pleural mesothelial cells. Am J Respir Cell Mol Biol 26 (2002), 384–387.
Sen, N., Ermis, H., Karatasli, M., Habesoglu, M.A., Eyuboglu, F.O., Propylthiouracil-associated eosinophilic pleural effusion: a case report. Respiration 74 (2007), 703–705.
Strong, D.H., Westcott, J.Y., Biller, J.A., Morrison, J.L., Effros, R.M., Eosinophilic “empyema” associated with crack cocaine use. Thorax 58 (2003), 823–824.
Cudzilo, C., Aragaki, A., Guitron, J., Benzaquen, S., Methotrexate-induced pleuropericarditis and eosinophilic pleural effusion. J Bronchology Interv Pulmonol 21 (2014), 90–92.
McCarthy, E., McClain, E., Methamphetamine-induced lung injury. Eur J Case Rep Intern Med 6 (2019), 1–3.
Camus, P., Methamphetamine. Available from: https://www.pneumotox.com/drug/view/479/methamphetamine.
Martínez García, M.A., Cases Viedma, E., Perpiñá Tordera, M., Sanchis-Aldás, J.L., Repeated thoracentesis: an important risk factor for eosinophilic pleural effusion?. Respiration 70 (2003), 82–86.
Naranjo, C.A., Busto, U., Sellers, E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981), 239–245.
Morris, M.T., Tarpada, S.P., Long-acting injectable paliperidone palmitate: a review of efficacy and safety. Psychopharmacol Bull 47 (2017), 42–52.
Macaluso, M., Oliver, H., Sohail, Z., Pharmacokinetic drug evaluation of paliperidone in the treatment of schizoaffective disorder. Expert Opin Drug Metab Toxicol 13 (2017), 871–879.